Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Rapport Therapeutics, Inc. - Common Stock
(NQ:
RAPP
)
30.98
+0.36 (+1.18%)
Streaming Delayed Price
Updated: 11:52 AM EST, Dec 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
48,976
Open
30.99
Bid (Size)
30.72 (100)
Ask (Size)
30.94 (200)
Prev. Close
30.62
Today's Range
30.00 - 31.40
52wk Range
6.430 - 42.27
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?
↗
December 22, 2025
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?
Via
The Motley Fool
Topics
Regulatory Compliance
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
December 22, 2025
As the curtains draw on 2025, the biotechnology sector has emerged as the undisputed champion of the equity markets, staging a dramatic year-end rally that has caught even the most optimistic analysts...
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
Performance
YTD
+68.5%
+68.5%
1 Month
+9.4%
+9.4%
3 Month
+16.2%
+16.2%
6 Month
+150.2%
+150.2%
1 Year
+71.8%
+71.8%
More News
Read More
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Rapport Therapeutics Stock Rockets 204% Pre-Market To Head Toward All-Time Highs – Here’s What Happened
↗
September 08, 2025
Via
Stocktwits
Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures
December 05, 2025
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Rapport Therapeutics to Present New Phase 2a Data Analysis Further Characterizing RAP-219 in Focal Onset Seizures at 2025 American Epilepsy Society Annual Meeting
November 25, 2025
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
This Extreme Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
↗
November 19, 2025
Via
Benzinga
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
November 07, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
Rapport Therapeutics Inc (NASDAQ:RAPP) Reports Q3 2025 Earnings Beat and Positive Phase 2a Seizure Data
↗
November 06, 2025
Via
Chartmill
Topics
Earnings
Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update
November 06, 2025
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Rapport Therapeutics to Participate in Upcoming Investor Conferences
November 05, 2025
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
September 11, 2025
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
September 10, 2025
Via
Benzinga
Rapport Announces Pricing of Public Offering of Common Stock
September 09, 2025
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Let's take a look at the stocks that are in motion in today's session.
↗
September 09, 2025
Via
Chartmill
Rapport Announces Proposed Public Offering of Common Stock
September 08, 2025
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Top movers analysis one hour before the close of the markets on 2025-09-08: top gainers and losers in today's session.
↗
September 08, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 08, 2025
Via
Benzinga
Top stock movements in today's session.
↗
September 08, 2025
Via
Chartmill
Gold Moves Higher; Robinhood Shares Jump
↗
September 08, 2025
Via
Benzinga
Rapport Therapeutics, Planet Labs, QuantumScape, EchoStar And Other Big Stocks Moving Higher On Monday
↗
September 08, 2025
Via
Benzinga
Nasdaq Surges 150 Points; Planet Labs Shares Jump After Q2 Results
↗
September 08, 2025
Via
Benzinga
Rapport Catapults Almost 200% After Succeeding In Hard-To-Treat Seizures
↗
September 08, 2025
Via
Investor's Business Daily
Rapport Reports Promising Epilepsy Study Outcomes, Plans Phase 3 Trials Next Year
↗
September 08, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 08, 2025
Via
Benzinga
Frequently Asked Questions
Is Rapport Therapeutics, Inc. - Common Stock publicly traded?
Yes, Rapport Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Rapport Therapeutics, Inc. - Common Stock trade on?
Rapport Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Rapport Therapeutics, Inc. - Common Stock?
The ticker symbol for Rapport Therapeutics, Inc. - Common Stock is RAPP on the Nasdaq Stock Market
What is the current price of Rapport Therapeutics, Inc. - Common Stock?
The current price of Rapport Therapeutics, Inc. - Common Stock is 30.98
When was Rapport Therapeutics, Inc. - Common Stock last traded?
The last trade of Rapport Therapeutics, Inc. - Common Stock was at 12/24/25 11:52 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
